GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: MDVN
Sector Perform $40

MEDIVATION INC (NASDAQ: MDVN) reiterated to Sector Perform with price target $40 by RBC Capital Mkts

Friday,  Nov 6, 2015  4:25 PM ET by Betsy O'Brien Harrison

RBC Capital Mkts reiterated MEDIVATION INC (NASDAQ: MDVN) to Sector Perform with
price target $40. Previously RBC Capital Mkts reiterated MEDIVATION INC (NASDAQ: MDVN) to Sector Perform on 08/30/2010, when the stock price was $4.99.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy